Sheffield Care and Research Centre for MND and SITraN

University of Sheffield

The Sheffield Motor Neurone Disorders clinic offers multidisciplinary care and support to patients and carers living with ALS.

UniversityShefield
University of Sheffield

We have a dedicated team who aim to provide a high level of care and support to people living with ALS. We are a regional centre that works closely with community teams ensuring that patients and their carers receive specialist knowledge and advice to support individuals. Sheffield is a major site for ALS clinical trials and clinical studies to improve symptom management and quality of life.

Contact
Location
385 Glossop Road, Sheffield, S10 2HQ, UK

Our Specialists

Pamela Shaw

Professor of Neurology

Professor Dame Pam Shaw is Professor of Neurology at the University of […]

Pamela Shaw
Current trials
Recruiting
Phase iii

PHOENIX trial

Industry trial
Amylyx Pharmaceuticals Inc is conducting a phase 3 trial to determine the safety and efficacy of their compound 'AMX0035' for the treatment of ALS.
Read more
Recruiting
Phase iii

ADORE Trial

Industry trial
Ferrer is conducting a phase 3 trial to evaluate the safety and potential efficacy of an investigational drug for people with Amyotrophic Lateral Sclerosis (ALS).
Read more
Recruiting
Phase iii

COURAGE-ALS Trial

Industry trial
In the COURAGE-ALS study, we are investigating the efficacy and safety of the drug ‘reldesemtiv’ for the treatment of ALS. This clinical trial is sponsored by Cytokinetics.
Read more
Recruiting
Phase ii

APL2-ALS-206 Trial

Industry trial
In this phase 2 study, we are investigating the safety and efficacy of the drug pegcetacoplan for the treatment of ALS. This trial is sponsored by Apellis Pharmaceuticals.
Read more
Active
Phase ii

RT001 in Amyotrophic Lateral Sclerosis

Industry trial
In this phase 2 trial, we will study the safety and efficacy of the compound RT001 in people living with ALS. This clinical trial is sponsored by Retrotope Inc.
Read more
Recruiting
Phase iii

TUDCA-ALS

Investigator initiated trial
This trial will evaluate the efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment for people with ALS.
Read more